Critical Care & Emergencies (all articles)
Consensus Statement | Aerosol therapy in adult critically ill patients
14 Jul, 2023 | 13:01h | UTC
RCT | Swallowing and oral-care program enhances oral-feeding resumption and reduces pneumonia post-extubation
14 Jul, 2023 | 12:44h | UTC
M-A | Adjunctive corticosteroids improve survival, clinical outcomes in severe community-acquired pneumonia
13 Jul, 2023 | 13:09h | UTCRelated:
Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis – Journal of General Internal Medicine (if the link is paywalled, try this one)
RCT | Hydrocortisone reduces mortality in severe community-acquired pneumonia
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Practice Guidance | Six steps to better care for older people in acute hospitals
12 Jul, 2023 | 14:00h | UTCSix steps to better care for older people in acute hospitals – British Geriatrics Society
News Release: New guidance outlines ‘Six steps to better care for older people in hospital’ – British Geriatrics Society
Myocarditis: a primer for intensivists
12 Jul, 2023 | 13:42h | UTCMyocarditis: a primer for intensivists – Intensive Care Medicine
Commentary on Twitter
Fulminant myocarditis in #ICU
🫀short/long‑term prognosis
🫀clinical suspicion, initial recognition, differential diagnoses
🫀initial management & temporary #MCS: IABP #ECMO #Impella
🫀endomyocardial biopsy
🫀immunomodulatory therapies
🔓#FOAMcc @yourICM
🖇️https://t.co/JIGm4p0tv5 pic.twitter.com/o4RctuurEL— Intensive Care Medicine (@yourICM) July 11, 2023
Retrospective Analysis | 18% of ICU patients develop sepsis-associated AKI, mostly stage 1, diagnosed by low urine output
12 Jul, 2023 | 13:39h | UTC
Commentary on Twitter
Fulminant myocarditis in #ICU
🫀short/long‑term prognosis
🫀clinical suspicion, initial recognition, differential diagnoses
🫀initial management & temporary #MCS: IABP #ECMO #Impella
🫀endomyocardial biopsy
🫀immunomodulatory therapies
🔓#FOAMcc @yourICM
🖇️https://t.co/JIGm4p0tv5 pic.twitter.com/o4RctuurEL— Intensive Care Medicine (@yourICM) July 11, 2023
Review | Head to toe ultrasound: a narrative review of experts’ recommendations of methodological approaches
12 Jul, 2023 | 13:32h | UTC
AASLD Guidance | Use of TIPS, variceal embolization, and retrograde transvenous obliteration in variceal hemorrhage
11 Jul, 2023 | 13:59h | UTC
Recommendations on the structure, personal, and organization of intensive care units
11 Jul, 2023 | 13:56h | UTC
Subarachnoid hemorrhage | ED presentation, evaluation, and management
11 Jul, 2023 | 13:49h | UTCSubarachnoid hemorrhage: ED presentation, evaluation, and management – emDocs
Related:
AHA/ASA Guideline for the management of patients with aneurysmal subarachnoid hemorrhage
M-A | Catheter-directed thrombolysis vs. systemic thrombolysis and anticoagulation in intermediate- or high-risk pulmonary embolism
11 Jul, 2023 | 13:47h | UTC
Review | Human-centered visualization technologies for patient monitoring are the future
11 Jul, 2023 | 13:34h | UTC
Practice Recommendation | Strategies to prevent MRSA transmission and infection in hospitals
10 Jul, 2023 | 14:02h | UTCCommentary: New guidelines recommend antibiotic stewardship for preventing MRSA – CIDRAP
Guideline | Acute liver failure
10 Jul, 2023 | 13:59h | UTCAcute Liver Failure Guidelines – The American Journal of Gastroenterology
Related:
EASL Clinical Practice Guidelines on acute-on-chronic liver failure – Journal of Hepatology
Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU
Acute-on-chronic liver failure: far to go—a review – Critical Care
RCT | Dual antiplatelet therapy proves noninferior to alteplase in minor ischemic stroke
10 Jul, 2023 | 13:58h | UTCDual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
See also: Visual Abstract
Review | Evaluation of acute adult disorders of consciousness for the general intensivist
10 Jul, 2023 | 13:37h | UTCState-of-the-Art Evaluation of Acute Adult Disorders of Consciousness for the General Intensivist – Critical Care Medicine (free for a limited period)
Personalized nutrition therapy in critical care: 10 expert recommendations
10 Jul, 2023 | 13:36h | UTCPersonalized nutrition therapy in critical care: 10 expert recommendations – Critical Care
How to avoid harm with feeding critically ill patients: a synthesis of viewpoints of a basic scientist, dietitian and intensivist
10 Jul, 2023 | 13:34h | UTC
Consensus Paper | Adult cardiac surgery-associated acute kidney injury
7 Jul, 2023 | 16:18h | UTC
Consensus Paper | The place of new antibiotics for Gram-negative bacterial infections in intensive care
7 Jul, 2023 | 16:15h | UTC
Review | Acute-on-chronic liver failure
7 Jul, 2023 | 16:09h | UTCAcute-on-chronic liver failure: far to go—a review – Critical Care
Related:
EASL Clinical Practice Guidelines on acute-on-chronic liver failure – Journal of Hepatology
Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU
M-A | Clinical tests for confirming tracheal intubation or excluding esophageal intubation
3 Jul, 2023 | 14:19h | UTC
M-A | Higher versus lower blood pressure targets after cardiac arrest
3 Jul, 2023 | 14:18h | UTC
Review | Respiratory challenges and ventilatory management in different types of acute brain-injured patients
3 Jul, 2023 | 14:17h | UTC
RCT | Substituting saline with balanced crystalloid solution reduces delayed graft function in kidney transplantation
30 Jun, 2023 | 14:56h | UTCSummary: The BEST-Fluids study was a pragmatic, multicentre, double-blind, randomized controlled trial carried out across 16 hospitals in Australia and New Zealand, aimed at comparing the use of balanced crystalloid solution (Plasma-Lyte 148) and saline in deceased donor kidney transplantation. The sample size comprised of 808 participants, who were either adults or children of any age, with the primary outcome defined as delayed graft function (DGF) occurring within 7 days post-transplantation.
Findings from the trial revealed that the balanced crystalloid group experienced less DGF than the saline group, with 121 out of 404 participants (30%) and 160 out of 403 participants (40%), respectively. This result yields an adjusted relative risk of 0.74 and an adjusted risk difference of 10.1%.
The study suggests that balanced crystalloid solution significantly reduces the incidence of DGF compared to saline. As no significant safety concerns were raised during the trial, the researchers recommend the use of balanced crystalloid solution as the standard-of-care intravenous fluid in deceased donor kidney transplantation. However, the study doesn’t indicate any significant differences in graft failure or mortality rates, which calls for further research.
Article: Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial – The Lancet (free registration required)


